Fusion event
HBV-chr19 integration
Disease
Hepatocellular carcinoma (HCC)
Quality evaluation
Normal
Integrated sequence
CGTTGCCCGGCAACGGCCAGGTCTGTGCCAAGTGTTTGCTGACGCAACCCCCACTGGCTGGGGCTTGGTCATGGGCCATCAGCGCATGCGTGGAACCTTT| |TCGGCTCCTCTGCCGATCCATACTGCGGAACTCCTAGCCGCTTGTTTTGCTCGCAGCAGGTCTGGAGCAAACATTATCGGGACTGATAACTCTGTTGTCC
End
58314820/57803452 (Hg38)
Nearest miRNA
hsa-let-7e/Upstream/2415210; hsa-mir-10394/Downstream/531236;
Upstream sequence
catacattcccttttatagcttttcttacgactttcacaatcttcaacatgtcttaactttctgccttccttttacactatttttttcctaGTTTCACCT
Downstream sequence
CCTTTGTCTTCTTTTGAtttctgtctcttccagtttctctcttactctttccttctatttctttctctcatttgcactctattttccgctctctcatccc
Yang, L., et al. Molecular Characterization of HBV DNA Integration in Patients with Hepatitis and Hepatocellular Carcinoma. J Cancer ,2018,9(18): 3225-3235.